Quantcast
Last updated on April 16, 2014 at 6:17 EDT

Latest Ulceration Stories

2013-08-01 23:18:42

Saturday, September 21st, 2013 @ SugarHouse Casino Philadelphia, PA (PRWEB) August 01, 2013 The Philadelphia/Delaware Valley Chapter of the Crohn’s Colitis Foundation of America (CCFA) proudly presents the 18th Annual Sippin’ by the River on Saturday, September 21st, rain or shine, from 1pm-5pm. After taking a short hiatus from the Philadelphia side of the Delaware waterfront, the Sippin’ by the River team is pleased to announce this year’s location and event sponsor: SugarHouse...

2013-07-31 23:32:47

Crohn’s Disease and Ulcerative Colitis More Common Amongst Ashkenazi Jews New York, New York (PRWEB) July 31, 2013 Individuals seeking to learn about Crohn’s disease and ulcerative colitis (collectively known as inflammatory bowel disease, or IBD) can self-educate at GeneSights, the free online education resource presented by the Program for Jewish Genetic Health of Yeshiva University/Albert Einstein College of Medicine. IBD affects more than 1.4 million Americans and its prevalence...

2013-06-25 19:10:06

Researchers from UH Rainbow Babies & Children's Hospital report reasons behind the increase are unclear The largest investigation to date has found a dramatic increase in the number of hospitalizations for children with inflammatory bowel disease (IBD) during the past decade in the United States. The new study, published online and scheduled for the August 2013 print issue of the Journal of Investigative Medicine, found a 65 percent increase in IBD hospital discharges from 2000 to...

2013-04-15 23:00:43

Annual CCFA Spring Patient Education Day at Thomas Jefferson Hospital On Sunday, April 28, 2013. Philadelphia, PA (PRWEB) April 15, 2013 On Sunday, April 28, 2013, the Philadelphia/Delaware Valley Chapter of the Crohn´s & Colitis Foundation of America (CCFA) will proudly hold the Annual Spring Patient Education Day at Thomas Jefferson Hospital. This free program provides a supportive environment for patients, families and caregivers to learn about Crohn's disease and ulcerative...

2013-04-02 12:31:42

NEW YORK, April 2, 2013 /PRNewswire-iReach/ -- The Johns Hopkins University School of Medicine (JHUSOM) and DKBmed, LLC, have collaborated to create My Daily PACE, a mobile phone-based tool designed to help people with ulcerative colitis remember to take their medications and to track their symptoms. The tool is part of PACE UC: Persistence, Adherence, and Compliance Education in Ulcerative Colitis, an educational program created by JHUSOM and DKBmed. People with ulcerative colitis are...

2013-03-07 12:26:58

OSAKA, Japan, March 7, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD). If...

2012-12-13 12:24:26

OAKLAND, Calif., Dec. 13, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2013 Innovator Awards Program for Inflammatory Bowel Disease (IBD). The Program supports "out-of-the-box" innovative research projects that are potentially transformative to the Foundation's efforts to diagnose, treat and/or cure IBD. The Program is open to tenure track professors (or the equivalent) at all levels from any scientific discipline and from any non-profit research...

2012-10-31 15:23:47

CAMBRIDGE, Mass., Oct. 31, 2012 /PRNewswire/ -- ViThera Pharmaceuticals, Inc, a developer of novel therapeutics based on engineered probiotic bacteria, announced today the publication of breakthrough data validating its approach for the delivery of elafin in treating gastrointestinal inflammation. The results were published today by the journal Science Translational Medicine and show use of recombinant probiotic and non-pathogenic food-strain bacteria to deliver elafin, a protein designed to...

2012-08-28 06:28:53

OKLAHOMA CITY, Aug. 28, 2012 /PRNewswire/ -- Altheus Therapeutics announced today it has randomized its first patient in a comparator-controlled Phase 2 efficacy study of Zoenasa®, a novel combination therapy for ulcerative colitis (UC). Zoenasa is a fixed-dose combination of mesalamine (current standard of care in UC) plus a second potent anti-inflammatory agent not previously used in this indication. In multiple animal models and one human study the combination has shown to be...

2012-08-24 06:23:32

OAKLAND, Calif., Aug. 24, 2012 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation (KRF) announced today the recipients of its 2012 Innovator Awards and its 2012 Breakthrough Awards for Inflammatory Bowel Disease (IBD) research. Innovator Award recipients will each receive a $100,000 grant to support their respective innovative research projects. Breakthrough Awards are extended to existing KRF Innovator Award recipients, whose projects have demonstrated significant promise of...